Endocrine dysfunction and surveillance following hematopoietic stem cell transplantation: A clinical practice guideline update
Year: 2026
Type: article
Abstract: Endocrine disorders are the most common long-term complications after hematopoietic stem cell transplantation (HSCT). They can affect growth, thyroid, adrenal, gonadal function, bone health, and metabolism. In 2021, the Brazilian Society of Bone Marrow Transplantation (SBTMO) published guidelines for endocrine follow-up after HSCT, which were updated in 2023, providing practical support for monitoring and managing transplant survivors. Since then, these guidelines have been reinforced, with the main shift being toward personalized monitoring strategies. In this approach, the intensity and frequency of endocrine surveillance are adjusted according to each survivor’s treatment exposures and overall risk, rather than following fixed screening schedules. The scope of follow-up has also expanded to include fertility preservation and transition to adult care. Rather than introducing entirely new recommendations, current practice reflects a refinement of existing approaches. Even so, many recommendations still rely on moderatequality evidence, underscoring the need for prospective multicenter studies.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: hematopoietic stem cell transplantation, endocrine dysfunction, endocrine surveillance, late complications, transplant survivors, personalized monitoring, thyroid function, adrenal function, gonadal function, bone health, fertility preservation, transition to adult care, growth disorders, metabolic disorders
Open Access status: diamond
OpenAlex ID: W7225986606
